ExpreS2ion Biotech Holding AB (EXPRS2) Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Bent Frandsen, was filed 17 Nov 2024.
ExpreS2ion Biotech Holding AB (EXPRS2): what insiders have been doing
ExpreS2ion Biotech Holding AB (EXPRS2) is a listed company. Its insiders report their share dealings to Finansinspektionen. Over the twelve months to 25 October 2026, 5 filings were filed, from 2 insiders.
All open-market trades in the period are sales: 4 sales worth €244, by 1 insider, with no purchase on record. One trade stands out by size: a sale of €115 from Bent Frandsen, disclosed on 30 April 2026.
Between a trade and the moment it shows up on Finansinspektionen, the median delay is 10 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (1,028 companies, median 9 filings), a count of 5 filings is below the norm. Our records for ExpreS2ion Biotech Holding AB (EXPRS2) go back to 2017, with 28 purchases and 74 sales on the open market in total.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -68.3%Entry 171.31 · Close at T+365 54.36
- -63.2%Entry 180.74 · Close at T+365 66.44
- -77.5%Entry 700.10 · Close at T+365 157.59
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
- 66,843 shares@ SEK 1.60BTU (betald tecknad unit)ISIN SE0028501155FI:csv-fc1ec2900a5d42569be5
- 56,588 shares@ SEK 0.0102Teckningsrätt/UniträttISIN SE0028501148FI:csv-a1193e8f42cc909d2883
- 76,158 shares@ SEK 0.0106Teckningsrätt/UniträttISIN SE0028501148FI:csv-28b0c7a81b568664ed3c
- 121,230 shares@ SEK 0.0102Teckningsrätt/UniträttISIN SE0028501148FI:csv-281fd337b797f10f7a88
- 477 shares@ SEK 0.011Teckningsrätt/UniträttISIN SE0028501148FI:csv-275deb2a2b599574cc3e
- 105,000 shares@ SEK 14.65WarrantISIN SE0022088118FI:csv-5306cc490123cd6c7227
- 2,121 shares@ SEK 14.651.5% of flowAktieISIN SE0008348262FI:csv-67651e84cbdd597d71a7
- 10,000 shares@ SEK 14.65WarrantISIN SE0022088118FI:csv-b85cf8a8792898827963
- 250 shares@ SEK 14.651.4% of flowAktieISIN SE0023261292FI:csv-7d075373f3dbe114c62a
- 196,800 shares@ SEK 14.65WarrantISIN SE0022088118FI:csv-756c574a55a30f66452d
- 4,920 shares@ SEK 14.653.3% of flowAktieISIN SE0023261292FI:csv-c3895b6ee1bd7f34ecbf
- 2,625 shares@ SEK 17.910.6% of flowAktieISIN SE0023261292FI:csv-8509b59e717c8473c53e
- 105,000 shares@ SEK 17.9125.3% of flowWarrantISIN SE0022088100FI:csv-e5c78b1694700db28b8e
- 250 shares@ SEK 17.910.7% of flowAktieISIN SE0023261292FI:csv-37515891ffa6bae7c7d1
- 10,000 shares@ SEK 17.9128.9% of flowWarrantISIN SE0022088100FI:csv-7671bedeb2e8ac7beb88
- 2,121 shares@ SEK 17.911.0% of flowAktieISIN SE0008348262FI:csv-ccf2b0a2774a5e2708a7
- 84,840 shares@ SEK 17.9139.1% of flowWarrantISIN SE0022088100FI:csv-e9a4243a8a19b8b5994a
- 7,848 shares@ SEK 17.911.6% of flowAktieISIN SE0008348262FI:csv-672790ca7fe44213eb79
- 313,920 shares@ SEK 17.9163.3% of flowWarrantISIN SE0022088100FI:csv-54cb13e3c5a7eecb1481
- 117,108 shares@ SEK 0.0430.1% of flowWarrantISIN SE0022088100FI:csv-2e9b7695b5212f566e71Canonical exit: 12 Feb 2025 (T+90)
- 10,000 shares@ SEK 1.001.6% of flowBTU (betald tecknad unit)ISIN SE0022088191FI:csv-74f6ad15515d16ca5b58
- 196,812 shares@ SEK 1.002.2% of flowBTU (betald tecknad unit)ISIN SE0022088191FI:csv-be84b3e1c3c8d80bb8eb
- 843,962 shares@ SEK 0.00350.0% of flowTeckningsrätt/UniträttISIN SE0022088183FI:csv-f850620b9f30ddef2977
- 336,910 shares@ SEK 0.00230.0% of flowTeckningsrätt/UniträttISIN SE0022088183FI:csv-4afedbeed0501c9547a0
- 578,060 sharesTeckningsrätt/UniträttISIN SE0022088183FI:csv-1955739cca4cf9282669
25 of 169 declarations
About ExpreS2ion Biotech Holding AB (EXPRS2)
ExpreS2ion Biotech Holding AB is a biopharmaceutical company focused on developing vaccines and therapies based on its protein technology platform. It is listed on the XSTO market under the symbol EXPRS2.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations